News
COVID-19: Thromboembolic events high despite prophylaxis
October 27, 2020
“Standard prophylaxis as recommended in the guidelines is a low dose of low-molecular-weight heparin once daily, but these results suggest [patients] probably need higher doses.”
News
‘Cautious’ DOAC underdosing in AFib may push mortality higher
September 21, 2020
Risk-averse clinicians might be doing more harm than good by prescribing direct oral anticoagulants at lower-than-recommended dosages in hope of avoiding bleeding complications, suggests a study.
![1]()
News
HOME-PE trial clarifies which pulmonary embolism patients to treat at home
September 1, 2020
“Who’s happy with the HOME-PE trial? I think everybody.” – Dr. Stavros V. Konstantinides
![1]()
News
ESC’s revised NSTE-ACS guidelines embrace hsT, personalized anti-ischemia treatments
August 31, 2020
The first guideline update in 5 years for non ST-elevation ACS stresses high sensitivity troponin for diagnosis and tailored antiplatelet treatments.
![1]()
News
Continued extension of time for thrombolysis in stroke
August 12, 2020
Is thrombolysis beneficial between 4.5 and 9 hours after onset of stroke in patients with hypoperfused but salvageable regions of brain detected on automated perfusion imaging?
News
HM20 Virtual Product Theater: Aug. 12
August 6, 2020
Hear from Dr. Michael Oleksyk, clinical assistant professor at Florida State University, Pensacola, to learn more about venous thromboembolism prophylaxis, as well as treatment options for patients with deep vein thrombosis and/or pulmonary embolism.
![1]()
News
Patent foramen ovale linked with increased risk of ischemic stroke in PE
August 6, 2020
Is patent foramen ovale (PFO) associated with increased risk of ischemic stroke in patients diagnosed with acute pulmonary embolism (PE)?
![1]()
News
No rise in major hemorrhagic events with antiplatelet therapy after ICH
August 3, 2020
Does the risk of increased recurrent intracerebral hemorrhage (ICH) exceed the benefits of decreased vaso-occlusive events for patients resuming antiplatelet therapy following an ICH?
![1]()
Opinion
Hematologic manifestations of COVID-19
July 29, 2020
Dr. Alan P. Lyss examines a review on extrapulmonary manifestations of COVID-19, focusing in on hematologic effects.
News
Low-dose prasugrel preserves efficacy but lowers bleeding in elderly
July 23, 2020
In an ISAR-REACT 5 substudy of elderly ACS patients, low-dose prasugrel was favored over ticagrelor.
